When blood clots in a test-tube, fibrin strands form which enmesh the red blood cells and a clear serum is exuded as the clot retracts. When blood is shed into the cavity of a synovial joint it may coagulate in part, forming a relatively soft clot, but much of it remains apparently unaltered as a blood-like fluid. The red blood cells are not caught up in a fibrin network and there is no separation of a clear serum. This failure of normal coagulation within a joint has interested many writers (Jaffe, 1897; Vaubel, 1933; Jorpes, 1939; Ropes and Bauer, 1953) . Astrup and Sjolin (1958) found that thromboplastic activity in human synovial and capsular tissues was very low when compared with almost all other tissues. The initiation of coagulation in an uninjured or slightly injured joint therefore depends on blood thromboplastins alone, the condition under which blood clots in vitro. The possibility of the existence of an intra-articular anticoagulant (antithrombin) has been investigated (Harrold, 1961) , but no excess of this was found in haemarthrosis fluid when compared with plasma. Not only was the incoagulability of haemarthrosis fluid not corrected by the addition of excess thrombin, but by the use of specific antisera and of staphylococcal coagulase, it was shown that the failure to clot was caused by the absence of fibrinogen. The problem is thus reduced to a study of the fate of fibrinogen within the joint cavity.
Because of the persistence of fibrin deposits in the joints of rheumatoid arthritis, there has been much recent interest in the fibrinolytic powers ofnormal and diseased joint tissues (Bach Andersen and Gormsen, 1970; Caughey and Highton, 1967; Bamhart, Riddle, Bluhm, and Quintana, 1967) . The elucidation of the mechanism whereby, in the otherwise normal joint, fibrinogen and fibrin are eliminated from the joint space has thus become of wider significance. Ex- periments in which citrated plasma was injected into the rabbit knee have shown that the fibrinogen level falls to zero in a little over 1 hour without the forAccepted for publication July 6, 1972 mation of an equivalent fibrin clot (Harrold, 1960) . No fall occurs when heparin is added nor when the plasma is injected into the knee of a dead rabbit. It was suggested from this work that lysis of the fibrinogen was occurring in the joint cavity, a lysis occurring in competition with the clotting reaction catalysed by thrombin. The development of new techniques, particularly the estimation of fibrin degradation products (Merskey, Kleiner and Johnson, 1966) , has allowed this hypothesis to be examined more closely and has required its modification. This paper reports studies on the fate of fibrinogen within synovial joints using both immunological and radioisotope techniques.
Immunological studies MATERIAL AND METHODS
The tanned red cell haemagglutination inhibition immunoassay (TRCHII) of Merksey and others (1966) 
METHOD
Labelled plasma, 2-0 to 2 5 ml., was injected into the knee of an anaesthetized rabbit. Samples of about 0 I to 0-2 ml. were aspirated at 20-minute intervals. Each sample was placed in a previously weighed tube and by reweighing the tube its exact size was measured. The total radioactivity was assayed and then thrombin added and the mixture incubated for 30 minutes. The clot was extracted, washed, and assayed for the coagulable portion of the radioactivity. At the end of the experiment, 80 to 90 minutes later the animal was killed and the joint widely opened, residual fluid and clot being collected and the cavity washed out with saline. The joint tissues were carefully excised and separately examined. In 22 experiments human fibrinogen was used, in twelve rabbit. There was no clear difference in the behaviour of the two labelled preparations. New Zealand Red rabbits, 3 to 12 months old, were used in all experiments
The rabbit knee joint as an experimental model The rabbit knee joint, for all its convenience, has grave defects as a test-tube in that, in the first place injected fluid leaks from the joint, and secondly fibrinogen-free synovial fluid enters the joint during the course of the experiment. Dye studies have shown that fluid is lost into the upper leg along the tendon of tibialis anterior and is also rapidly absorbed through the synovial membrane itself. In twenty experiments the total loss of fluid during the 80 minutes of each experiment averaged 37 per cent., the range being 22 to 50 per cent. and the standard deviation 7 9 per cent.
When plasma containing labelled human albumin was injected into the rabbit knee joint, the concentration of the label fell by 28 A third difficulty arises when studying fibrinogen, for accidental initiation of the clotting mechanism may cause a portion of the fibrinogen under study to be inadvertently precipitated as fibrin. In fourteen experiments using labelled citrated plasma, fibrin clot recovered from the joint at the end of the experiment accounted for from 0 to 46 per cent. of the total injected, the average being 19 per cent. No such clot formation occurred when heparinized plasma was used.
Results

EXPERIMENTAL HAEMARTHROSES
Experiment I A 3-months-old female rabbit was anaesthetized with nembutal and ether. Blood was taken by cardiac needle puncture into a siliconed syringe and 3 0 ml. immediately injected into the right knee, a control sample being placed in a testtube in a water-bath at 37°C. Half an hour later a similar injection was made into the left knee and a second control set up. One hour after the start of the experiment the animal was killed, the knees explored, and bloody fluid collected from each joint, any soft clots found being discarded. Both control samples had clotted well and clear serum was collected from these. After the addition of a drop of epsilon-amino caproic acid (0 025 ml. of a 100 mg./ml. solution) to prevent further proteolysis and a drop of thrombin (1000 u./ml.) to all these specimens each was incubated for one hour and then spun. The supernatant fluids were tested for fibrin degradation products (FDP) .
No excess of FDP was found in the 30 or 60-minute haemarthrosis fluids. The amount found in the 30-minute fluid and the control serum was equivalent to 0-2 per cent. of the original plasma fibrinogen, and in the 60-minute fluid it was 0 4 per cent. There was thus no evidence of the liberation of FDP within the joint cavity. Further experiments in which plasma rich in FDP produced by incubation with varidase (streptokinasestreptodomase) was introduced into the rabbit knee produced no evidence of a major block to the detection of FDP by the immunoassay after the joint passage.
These experiments therefore indicated that the fall in fibrinogen level demonstrable in citrated plasma within the rabbit knee joint was not associated with a corresponding liberation of fibrin degradation products into the joint fluid.
HUMAN HAEMARTHROSES
Fluids from fourteen haemarthroses of clinical origin were available. E.a.c.a. was added to each on collection and the cells and debris were separated in a centrifuge. Specimens were collected from 8 hours to 5 days after the injury responsible. Each was stored at 4°C until testing. One had to be discarded because non-specific agglutination and haemolysis repeatedly prevented attempts at assay. Details of the results of the TRCHII in the others are set out in Table I . The level of FDP in these fluids ranged from 0 05 to 12 per cent. (average 4 4). In the ten cases in which titrations were done against a control plasma of known fibrinogen content, the levels of FDP were equivalent to from 0-125 to 26 mg. fibrinogen per 100 ml. There was no apparent relation between the level of FDP and the age of the haemarthrosis or the age of the patient, but the lowest level of FDP was found in a case of spontaneous haemarthrosis into an otherwise uninjured joint.
I125-LABELLED FIBRINOGEN
The results of thirteen experiments are shown in Fig.  1 The fall of fibrinogen level noted in citrated plasma injected into the rabbit knee was much reduced when heparin (5 u./ml.) was added and when the experiment was done on the recently dead animal (Fig. 3) . Synovial membrane from the rabbit joints injected with labelled plasma was carefully excised, weighed, and assayed for radioactivity. In two experiments comparison was made with the synovial tissues of the opposite knee which had received as a control an identical volume of serum prepared from the same labelled plasma. Label in the synovial tissues of the control knee represented that derived from the uncoagulable portion of the original labelled plasma. Excess label in the tissues of the test knee represented label derived from the fibrinogen in that joint. The results of these two experiments are shown inTable II. The synovial membrane showed activity equivalent to 24 per cent. of the total fibrinogen injected when the human preparation was used and 19 per cent. with labelled rabbit fibrinogen. In thirteen further experiments the proportion of the total label injected that was later indentifiable in the synovial membrane excised varied widely and rather unpredictably from 3-1 to 28 per cent. Activity was highest in the thin tissue lining the suprapatellar pouch and posterior recesses and lowest per unit weight in the fat pads. Other joint tissues, cartilage, menisci, and bone contained less than 0-2 per cent. ofthe total label. The histogram is that in Fig. 1 (Table III) . If the loss with heparinized plasma is compared with that with the series of fourteen experiments using citrated plasma, the difference is statistically significant at a level of P < 0 01. Similarly, in two experiments with animals whose circulation had been stopped immediately before injecting the plasma, the fibrinogen loss was only 48 and 43 per cent. 
Discussion
The present study has shown that fibrinogen injected into the knee joint of the rabbit disappears rapidly and almost completely. Its disappearance cannot be accounted for by the small amount of fibrin clot formed or by the appearance of free fibrin degradation products in the joint fluid. Some loss can be accounted for by the leakage from the joint space along the tendon oftibialis anterior and by a probable dilutional effect by the entry of new, fibrinogen-free synovial fluid into thejoint. These factors alone could not account for the marked fall in fibrinogen levels recorded. Experiments with fibrinogen labelled with I125 showed that up to 24 per cent. of the fibrinogen label injected into the joint space could be found in the excised synovial membrane, suggesting that this tissue may be a route for the elimination or absorption of fibrinogen from the joint. The effects of circulatory arrest suggest that the fibrinogen is carried away in the blood stream and implies that it has diffused through the normally impermeable capillary wall, presumably as degradation products. Heparin would not normally be expected to affect such loss by simple diffusion, but it must be remembered that as well as inhibiting the action of thrombin it is an inhibitor of many other proteases. If its action in preserving the fibrinogen level of the joint plasma were by virtue of its anticoagulant effect alone, one would expect, because of the sustained higher fibrinogen levels, a greater total diffusion of fibrinogen from the joint than that observed with citrated plasma which on this hypothesis less effectively prevented coagulation and in consequence allowed a considerable fall in fibrinogen level. In fact the opposite was observed. Heparin, while maintaining the plasma fibrinogen level, at the same time decreased the total loss from the joint. It is suggested that the heparin blocked a system in the synovial membrane which facilitates the absorption of fibrinogen by proteolytic breakdown.
Sunmmary
Studies by immunological methods and radioisotope labelling are reported which show that, in both experimental and clinical haemarthroses, the disappearance of fibrinogen from the joint contents is not associated with the liberation of a corresponding quantity of fibrin degradation products. After the injection of plasma into the rabbit knee radioactive label from the labelled fibrinogen was identifiable in significant quantities in the synovial membrane. Evidence is put forward for the selective absorption of fibrinogen from the joint cavity.
